Dark

FWP
Forward Pharma A/S
stock NASDAQ

Inactive

Dec 27, 2022

1.95USD+7.735%(+0.14)43,354

Pre-market

0.00USD-100.000%(-1.81)0

After-hours

0.00USD0.000%(0.00)0

OverviewHistoricalExchangesShortsMore

open chart

CEO

Claus Svendsen

Headquarters

Copenhagen K, Koebenhavn K, Denmark

Industry

Biotechnology

Last Split

Dec 6, 20191for7reverse

NLNK RTRX GNCA ADRO XLV

Profile

Forward Pharma A/S is a Danish biopharmaceutical company preparing to initiate a clinical trial using FP187, a proprietary formulation of dimethyl fumarate, or DMF, for the treatment of multiple sclerosis, or MS, patients.

.dark-mode .XMDMJb{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .XMDMJb{ color: #333333; background-color: white; border: 2px solid #333333; }FWPForward Pharma A/Sstock NASDAQ

FWP
Forward Pharma A/S
stock NASDAQ